Clinicopathological significance of HER2/neu genetic heterogeneity in HER2/neu non-amplified invasive breast carcinomas and its concurrent axillary metastasis

Genetic heterogeneity of HER2 in breast cancer: impact on HER2 testing and its clinicopathologic significance

(2012) Yi-ling Yang et al.   BREAST CANCER RESEARCH AND TREATMENT

‘Genetic heterogeneity’ in HER2/neu testing by fluorescence in situ hybridization: a study of 2522 cases

(2012) Martin C Chang et al.   MODERN PATHOLOGY

Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance

(2012) Hyesil Seol et al.   MODERN PATHOLOGY

Molecular Alterations Between the Primary Breast Cancer and the Subsequent Locoregional/Metastatic Tumor

(2012) R. Macfarlane et al.   ONCOLOGIST

HeterogeneousHER2Gene Amplification

(2011) Alastair I. Bartlett et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

HER2 genetic heterogeneity in breast carcinoma

(2011) C. Ohlschlegel et al.   JOURNAL OF CLINICAL PATHOLOGY

Genotypic Intratumoral Heterogeneity in Breast Carcinoma With HER2/neuAmplification

(2009) Matteo Brunelli et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases

(2009) S. J. Aitken et al.   ANNALS OF ONCOLOGY

Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

(2009) Maggie C. U. Cheang et al.   JNCI-Journal of the National Cancer Institute

HER2Status and Benefit from Adjuvant Trastuzumab in Breast Cancer

(2008) Soonmyung Paik et al.   NEW ENGLAND JOURNAL OF MEDICINE